Glycopyrrolate Injection
Product Images NDC 0143-9682

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0143-9682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glycopyrrolate Injection 1)

Chemical structure of glycopyrrolate illustrating its molecular formula C19H28BrNO3 and molecular weight of 398.33, showing the arrangement of rings, functional groups, and the bromide ion (Br-).*

FDA Label Image

Glycopyrrolate Injection 10

Label for Glycopyrrolate injection 0.2 mg/mL by Hikma Pharmaceuticals USA Inc. The label includes a QR code and printed identifiers such as GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The text appears in black on a white background.*

FDA Label Image

Ndc 0143-9682-01 Glycopyrrolate Injection, Usp 0.2 mg/ml Rx Only Contains Benzyl Alcohol For Im Or Iv Use 1 mL Single Dose Vial (Glycopyrrolate Injection 2)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a 1 mL single-dose vial for intramuscular or intravenous use. The label indicates it contains benzyl alcohol and is distributed by Hikma Pharmaceuticals USA Inc. The NDC number 0143-9682-01 is visible.*

FDA Label Image

Ndc 0143-9682-25 Glycopyrrolate Injection, Usp 0.2 mg/ml Rx Only Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Administration 25 X 1 mL Single Dose Vials (Glycopyrrolate Injection 3)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL by Hikma Pharmaceuticals USA Inc. The label states it is for intramuscular or intravenous use, contains benzyl alcohol preservative, and is not for use in newborns. The packaging includes 25 single dose vials of 1 mL each.*

FDA Label Image

Ndc 0143-9680-01 Rx Only Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Adminisration 5 mL Multiple Dose Vial (Glycopyrrolate Injection 4)

Label for Glycopyrrolate Injection, USP 1 mg per 5 mL (0.2 mg/mL) in a 5 mL multiple dose vial. The injectable drug is for intramuscular or intravenous use, contains benzyl alcohol as preservative, and is distributed by Hikma Pharmaceuticals USA Inc. The label includes storage instructions (20° to 25°C) and a note that it is not for use in newborns.*

FDA Label Image

Ndc 0143-9680-25 Rx Only Glycopyrrolate Injection, Usp 1 mg/5 mL (0.2 mg/ml) Not For Use In Newborns Contains Benzyl Alcohol For Im Or Iv Adminisration 25 X 5 mL Multiple Dose Vials (Glycopyrrolate Injection 5)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg per 5 mL) by Hikma Pharmaceuticals USA Inc. The label states it is for intramuscular or intravenous use, contains benzyl alcohol as a preservative, and includes storage instructions at 20° to 25°C. The package contains 25 x 5 mL multiple dose vials and is marked Rx only, not for use in newborns.*

FDA Label Image

Glycopyrrolate Injection 6

Label for Glycopyrrolate Injection USP 0.4 mg per 2 mL (0.2 mg/mL) in a 2 mL single dose vial. The label indicates it contains benzyl alcohol and is for intramuscular (IM) or intravenous (IV) use. Distributed by Hikma Pharmaceuticals USA Inc. Includes NDC 0143-9681-01 and space for lot and expiration dates.*

FDA Label Image

Glycopyrrolate Injection 7

Glycopyrrolate Injection, USP 0.4 mg per 2 mL (0.2 mg/mL) multi-dose vial label. It is indicated for intramuscular or intravenous use and contains benzyl alcohol as a preservative. The label includes storage instructions and notes it is not for use in newborns. Distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Glycopyrrolate Injection 8

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL (4 mg per 20 mL) injection solution. The label states it is for intramuscular (IM) or intravenous (IV) use, not for use in newborns, and contains benzyl alcohol as a preservative. Distributed by Hikma Pharmaceuticals USA Inc. Dosage instructions refer to the package insert.*

FDA Label Image

Glycopyrrolate Injection 9

Label for Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg per 20 mL) by Hikma Pharmaceuticals USA Inc. The label indicates it contains benzyl alcohol as a preservative and is for intramuscular or intravenous use. It includes storage instructions and specifies it is not for use in newborns. Package contains 10 x 20 mL multiple dose vials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.